ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
APEH | Acylaminoacyl-peptide hydrolase | Enzymes Plasma proteins
| | | | | Expressed in all |
C1S | Complement component 1, s subcomponent | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CELA3A | Chymotrypsin-like elastase family, member 3A | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CELA3B | Chymotrypsin-like elastase family, member 3B | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CFB | Complement factor B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CLPP | Caseinolytic mitochondrial matrix peptidase proteolytic subunit | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
CMA1 | Chymase 1, mast cell | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CPVL | Carboxypeptidase, vitellogenic-like | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CTRC | Chymotrypsin C (caldecrin) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CTRL | Chymotrypsin-like | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CTSA | Cathepsin A | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
DPP8 | Dipeptidyl-peptidase 8 | Enzymes Plasma proteins
| | | | | Expressed in all |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
EPHX1 | Epoxide hydrolase 1, microsomal (xenobiotic) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GZMH | Granzyme H (cathepsin G-like 2, protein h-CCPX) | Enzymes Predicted secreted proteins
| | | | | Mixed |
HGFAC | HGF activator | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HP | Haptoglobin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
HTRA1 | HtrA serine peptidase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
HTRA4 | HtrA serine peptidase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
KLK10 | Kallikrein-related peptidase 10 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KLK15 | Kallikrein-related peptidase 15 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KLK3 | Kallikrein-related peptidase 3 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK4 | Kallikrein-related peptidase 4 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
KLK5 | Kallikrein-related peptidase 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
KLK7 | Kallikrein-related peptidase 7 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KLK8 | Kallikrein-related peptidase 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
LACTB | Lactamase, beta | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
LONP1 | Lon peptidase 1, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PCSK2 | Proprotein convertase subtilisin/kexin type 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PIDD | P53-induced death domain protein | Enzymes
| | | | | Expressed in all |
PLG | Plasminogen | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PREP | Prolyl endopeptidase | Enzymes Plasma proteins
| | | | | Expressed in all |
PROC | Protein C (inactivator of coagulation factors Va and VIIIa) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PRSS1 | Protease, serine, 1 (trypsin 1) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
PRSS21 | Protease, serine, 21 (testisin) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PRSS3 | Protease, serine, 3 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PRSS36 | Protease, serine, 36 | Enzymes Predicted secreted proteins
| | | | | Mixed |
PRSS50 | Protease, serine, 50 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
PRSS54 | Protease, serine, 54 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
TMPRSS11E | Transmembrane protease, serine 11E | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |